RUNX2 and ocular melanoma: EGCG(1.25) administration resulted in higher expression of the early osteogenic markers collagen type 1 α 1 (COL1A1) and Runt-related transcription factor 2 (RUNX2) compared with the expression levels observed with OM and OM(Dex) treatment at day 1.